Advertisement
Skip to Content

ARK Genomic Revolution ETF ARKG

Medalist Rating as of | See ARK Investment Hub

Morningstar’s Analysis ARKG

Will ARKG outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A middling People rating and a subpar Parent Pillar limit ARK Genomic Revolution ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ARKG

  • Current Portfolio Date
  • Equity Holdings 43
  • Bond Holdings 1
  • Other Holdings 2
  • % Assets in Top 10 Holdings 53.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
11.49
247,439,962
Healthcare
7.08
152,395,200
Healthcare
6.52
140,357,448
Healthcare
4.69
100,906,954
Healthcare
4.35
93,708,318
Healthcare
4.29
92,319,499
Healthcare
3.95
85,128,699
Healthcare
3.74
80,614,912
Healthcare
3.58
77,060,403
Healthcare
3.52
75,826,961
Healthcare